F&S Interactive Associates
Jason Franasiak
MD, FACOG, HCLD/ALD (ABB), Reproductive Medicine Associates of New Jersey; Thomas Jefferson University
Pietro Bortoletto
Reproductive Medicine, Weill Cornell Medicine - Center for Reproductive Medicine
Intramuscular progesterone optimizes live birth from programmed frozen embryo transfer: a randomized clinical trial
Vaginal-only progesterone replacement for programmed frozen embryo transfer significantly reduced live birth rates and should be avoided. Vaginal replacement supplemented with intramuscular progesterone every third day is an effective, patient-friendly alternative to daily intramuscular progesterone
The prolonged disease state of infertility is associated with embryonic epigenetic dysregulation
A prolonged disease state of infertility correlates with an altered methylome in individual human euploid blastocysts, impacting several signaling pathways and genomic imprinting regulation.
Latest Content
Prenatal urinary concentrations of phenols and risk of preterm birth: exploring windows of vulnerability
Mid-to-late pregnancy bisphenol A concentrations and early pregnancy paraben concentrations were associated with preterm birth among female infants only. Risk of preterm birth may be compound, sex, and window specific.
Utility of routine screening fetal echocardiogram in pregnancies conceived by in vitro fertilization
Routine screening with fetal echocardiography in pregnancies conceived by in vitro fertilization did not detect significantly higher rates of congenital heart disease, and most defects detected were clinically insignificant.
Perinatal outcomes of pregnancies resulting from assisted reproduction technology in SARS-CoV-2-infected women: a prospective observational study
Method of conception does not affect fetal or maternal outcomes in SARS-CoV-2 infected women, except for preeclampsia. High rate of operative delivery in SARSCoV-2 infected women, especially in in vitro fertilization pregnancies.